Burleson & Company, LLC Abb Vie Inc. Transaction History

Burleson & Company, LLC

$384 Million
Q4 2022

A detailed history of Burleson & Company, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Burleson & Company, LLC holds 37,600 shares of ABBV stock, worth $6.24 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares

37,600

Previous 32,586 15.39%

Holding current value

$6.24 Million

Previous $4.37 Million 39.03%

% of portfolio

1.58%

Previous 0.94%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $693,486 - $831,672	5,014 Added 15.39%	37,600 $6.08 Million
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $213,930 - $245,364	1,594 Added 5.14%	32,586 $4.37 Million
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $26,973 - $34,292	-196 Reduced 0.63%	30,992 $4.75 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $153,624 - $190,605	-1,164 Reduced 3.6%	31,188 $5.06 Million
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $81,539 - $103,170	-759 Reduced 2.29%	32,352 $4.38 Million

Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $132,893 - $150,854	-1,249 Reduced 3.64%	33,111 $3.57 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $22,935 - $25,551	218 Added 0.64%	34,360 $3.87 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $364,801 - $401,602	-3,566 Reduced 9.46%	34,142 $3.7 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $12,395 - $16,735	-154 Reduced 0.41%	37,708 $4.04 Million
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $6.93 Million - $8.14 Million	-80,695 Reduced 68.06%	37,862 $3.52 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $1.57 Million - $2.11 Million	21,452 Added 22.09%	118,557 $11 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $3.42 Million - $5.18 Million	52,988 Added 120.11%	97,105 $8.15 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $2,668 - $3,339	37 Added 0.08%	44,117 $3.85 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $227,168 - $273,122	3,607 Added 8.91%	44,080 $3.43 Million
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $923,873 - $1.18 Million	14,062 Added 53.24%	40,473 $2.66 Million
Q4 2018 Feb 27, 2019	SELL	$77.85 - $96.01 $149,705 - $184,627	-1,923 Reduced 6.79%	26,411 $2.08 Million
Q3 2018 Dec 06, 2018	BUY	$88.91 - $98.84 $930,620 - $1.03 Million	10,467 Added 58.58%	28,334 $2.54 Million
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $90,228 - $106,761	1,005 Added 5.96%	17,867 $1.66 Million
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $736 - $985	8 Added 0.05%	16,862 $1.6 Million
Q4 2017 Mar 19, 2018	BUY	$89.56 - $98.21 $1.51 Million - $1.66 Million	16,854	16,854 $1.63 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.

Account

Burleson & Company, LLC Abb Vie Inc. Transaction History